Nasopharyngeal carcinoma (NPC) has a high metastatic clinicopathological feature. As a carcinogen factor, N,N′-dinitrosopiperazine (DNP) is involved in NPC metastasis, but its precise mechanism has not been fully elucidated. Herein, we showed that DNP promotes NPC metastasis through upregulating miR-149. DNP was found to decrease Plakophilin3 (PKP3) expression, further DNP-decreased PKP3 was verified to be through upregulating miR-149. We also found that DNP induced proliferation, adhesion, migration and invasion of NPC cell, which was inhibited by miR-149-inhibitor. DNP may promote NPC metastasis through miR-149-decreased PKP3 expression. Therefore, DNP-increased miR-149 expression may be an important factor of NPC high metastasis, and miR-149 may serve as a molecular target for anti-metastasis therapy of NPC.
process of salt preservation is inefficient and becomes partially putrefied, consequently, these foods accumulate significant levels of nitrosamines, 17, 18 which are known carcinogens. 17, 19, 20 N,N′-Dinitrosopiperazine (DNP) is one predominant volatile nitrosamine in salted fish. 14, 21 The clinical assay and experiment study have documented that DNP, a specific carcinogen for NPC, is not only involved in NPC carcinogenesis, and but also associate with NPC metastasis. [22] [23] [24] Furthermore, DNP has been approved to increase NPC metastasis through inducing Ezrin phosphorylation and HSP70-2, AGR2, Clusterin expression. [25] [26] [27] MicroRNAs (miRNAs) are genome-derived noncoding RNA (ncRNA) molecules that govern target gene expression in a sequence-specific manner. 28, 29 They usually bind with partial complementarity to the 3′ untranslated region (3′-UTR) of the corresponding target mRNA. These bindings either cause target mRNA degradation or translational repression, which would lead to activation or inhibition of downstream signaling pathways. miRNAs are revealed to play critical roles in the control of cancer processes including proliferation, cell cycle, apoptosis, invasion, tumorigenesis, and metastasis. This provides a novel clue for miRNA-based therapies. miRNAs are aberrantly expressed in NPC cells and tissues, and involved in the regulation of tumor genes. 30, 31 Therefore, investigation of miRNA regulating pathways may offer insights into identification of new NPC oncotargets and development of new therapeutics. 32, 33 miR-149 was reported to be down-regulated in various cancer, negatively correlated with cancer WHO grade. [34] [35] [36] [37] Overexpression of miR-149 inhibits glioblastoma cell proliferation and migration. 37 miR-149 has also been proved to inhibit the proliferation and cell cycle progression in human gastric cancer. 38 miR-149 lowly expresses in some tumors, but highly expresses in other tumors. Various tumors have different miR-149 expressions, which may be decided by tumor heterogeneity. The upregulated miR-149 was reported in NPC tissue 39 and cell lines. 40 miR-149 had been confirmed to promote the proliferation, invasion and migration of NPC cell, 41 but its regulating mechanism is not clear. Moreover, a target scan analysis revealed that 3′-UTRs of Plakophilin3 (Pkp3) gene retains binding sites for miR-149, this implies that Pkp3 is a target gene of miR-149. PKP3 is a desmosomal plaque protein that belongs to p120 catenin subfamily of the armadillo family, and is found in desmosomes of most epithelial tissues with the exception of hepatocytes. 42 PKP3 loss was associated with tumor progression and metastasis in oral cavity and colon tumors. 43, 44 Our previous works showed that PKP3 expression is decreased in DNPinduced NPC metastasis. 45 In this article, we found that DNP induced NPC metastasis, conjugating the increased expression of miR-149 and the decreased PKP3, while miR-149-inhibitor decreased DNP-induced NPC metastasis through upregulating PKP3 expression. We think that DNP induces NPC metastasis through miR-149 downregulating PKP3
expression. These provide novel clues for NPC metastasis research.
| MATERIALS AND METHODS

| Cell cultures and treatment
Human NPC cell lines, 6-10B and 5-8F are sublines derived from cell line SUNE-1, were obtained from Sun Yat-sen University Cancer
Center (Guangzhou, China). 6-10B has a low metastatic ability, while the 5-8F has a high metastatic ability 25 (cell line authentication is showed in Supplemental Material). These cells were incubated in Dulbecco's Modified Eagle Medium (DMEM) containing 10% fetal bovine serum (FBS), L-glutamine, 100 IU/mL penicillin, 100 mg/mL streptomycin, and 0.25 mg/mL amphotericin (Life Technologies, Bethesda, MD) at 37°C in a humidified atmosphere of 5% CO 2 . 46 The 
| Antibodies and Western-blotting analysis
Antibody against PKP3 was purchased from Abcam (Cambridge, UK).
Antibody against GAPDH was purchased from kangchen Inc. (Shanghai, china). The secondary antibodies were purchased from Santa Southern Biotech, Inc. (Birmingham, USA). Western-blotting analysis was performed as previously described. 45 Briefly, after DNP treatment and gene transfection, the treated cells were disrupted with lysis buffer (1 × PBS, 1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% SDS, and freshly added 100 µg/mL PMSF, 10 µg/mL aprotinin, and 1 mM sodium orthovanadate). The cell lysates were subjected to centrifugation to obtain the supernatant. The protein concentration of supernatant sample was determined using the Bio-Rad Protein Assay (Bio-Rad Laboratories, Inc., Hercules, CA). Protein from supernatant sample was separated by electrophoresis, and transferred onto a nitrocellulose membrane. The protein membrane was incubated with specific antibody against PKP3, and then incubated with the peroxidase-conjugated secondary antibody.
The signal was developed using 4-chloro-1napthol/3,3-o-diaminobenzidine. The relative photographic density was quantified by scanning the photographic negative using a gel documentation and analysis system.
GAPDH was used as an internal control to verify basal level expression and equal protein loading. The abundance ratio to GAPDH was counted. The summed (extension + intensity) was used as the total score. We grouped all samples into the high expression group (total score ≥2) and the low one (total score <2) according to the protein expression.
| NPC biopsy samples
| miRNA sequencing analysis
After being treated with DNP at 80.0 µmol/L for 24 h, 26 6-10B cells were harvested, total RNA was extracted using TRIzol reagent (Invitrogen). Thirty to fifty milligrams total RNA was determined with an ND-1000 spectrophotometer (NanoDrop Technologies Inc., Wilmington, DE, USA). Small RNA library construction was performed as described. 47 Briefly, 15-30 nt small RNAs were isolated on 15% PAGE (7 M urea), and ligated to the 5′ and 3′ RNA adaptors. RT-PCR using primers with partial complementarity to the adaptors were performed. Four DNA pools from different samples were amplified from the first-strand cDNA and then sequenced using Hiseq2000
(Illumina, USA) at Beijing Genomics Institute at Shenzhen according to the manufacturer's protocol, and novel miRNAs were predicted as described. 47 The experiments were performed in triplicate.
| RT-PCR
RT-qPCR with gene-specific primers for SYBR® Green reporter was conducted as previously described. 26 Briefly, total RNA was isolated using Trizol (Invitrogen Co., Shanghai, China) reagent following the manufacturer's instructions. The resultant RNA was reverse-transcribed to cDNA using a PrimeScript® RT Master Mix kit (Takara Co., Dalian, China). Gene-specific primers were combined with SYBR® Premix Ex Taq™ (Takara) and amplified using an ABI 7500 Real-Time PCR System (Applied Biosystems, Foster City, CA). All qPCR reactions were independently conducted on five samples with prime sequence shown in Table 1 . The relative mRNA expression levels were calculated using the 2 −△△Ct method.
| Luciferase activity assay
3′ untranslated region (UTR) of Pkp3 gene, which contains miR-149 binding sites, was amplified using PCR with prime sequence shown in 
| Cell growth curve analysis and colony forming assay
According to the previous works, cell growth curve and colony of the treated cells were detected. 48 Briefly, the treated cells were well − OD value of control well)/OD value of control well × 100%. For colony forming assay, the cells were cultured in a 96-well culture plate at 1 × 10 3 cells/well. After being cultured for 7 days, the cell wells were stained with crystal violet, the number of cell colonies was calculated for three times. The colony formation efficiency (%) was calculated as the ratio of the number of colonies to the number of inoculated cells.
| Cell adhesion assay
Cell adhesion ability of the treated cells were detected using Cell adhesion assay according to the methods described previously with minor modifications. 49 Briefly, ninety-six-well dishes were pre-coated 
| Cell invasion and migration assay
Boden chamber invasion assay was performed with minor modifications as described previously by Tang et al. 25 Briefly, the transfected cells were treated with 0.2% trypsin, the treated cells were suspended.
The migration of the treated cells was directly tested using Boyden 
| Flow cytometric analysis
Cell apoptosis was detected by flow cytometry according to the previous describing. 50 Briefly, the treated cells were analyzed by flow cytometry using an Annexin V-FITC Apoptosis Detection Kit 
| Mitochondrial membrane potential assay
ΔΨm (mitochondrial membrane potential) was assessed using a flow cytometer (BD calibur). Briefly, the treated cells were stained with channel. The fluorescence intensity was acquired for 10 000 events.
The ratio of red (JC-1 polymer) to green fluorescence (JC-1 monomer) intensity was determined for each sample as a measure of ΔΨm.
| TdT-mediated dUTP nick end labeling (TUNEL) assay
To determine the percentage of apoptotic cells in the treated cells, we performed terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling assay (TUNEL) staining using the DeadEnd™ Fluorometric TUNEL System (Promega). First, the treated cells were cultured according to the corresponding groups, and then fixed with 4% paraformaldehyde in PBS for 10 min at room temperature. After being washed with PBS, the cell slides were permeabilized with 0.5%
Triton X-100 in 0.1% sodium citrate for 20 min. The slides were prebalanced by buffer for 10 min, and covered with TUNEL reaction mixture in a dark room at 37°C for 1 h, and then treated with termination by 2 × SCC converter at room temperature for 15 min.
After being washed, the slides were incubated with 4′,6-diamidino-2-phenylindole (DAPI) for 10 min at room temperature, and then washed and mounted in a fluorescence protector medium. The slides were 
| Tube formation assay
The tube formation assay was conducted as the described methods with minor modifications. 51 Briefly, 6-10B cells were transfected with miR-149, and incubated in medium with or without DNP for 24 h, and then 2 mL of the conditioned medium was collected. For tube formation assay, 96-well plate was coated with Matrigel (BD Biosciences, USA) and kept in 37°C for 2 h. Then, 2 × 10 4 HUVECs (Human Umbilical Vein Endothelial Cells) were suspended in 100 mL of the conditioned medium, and added to the precoated 96-well plate.
After incubation at 37°C for 24 h, the cell growth was taken photographs under microscope, and the tubular structures formed were counted. The experiments were performed in triplicate, and five fields from each chamber were counted and averaged.
| F-actin staining
The treated cells were fixed with 4% paraformaldehyde for 15 min at 
| Evaluation of the effect of DNP and miR-149 on NPC metastasis in nude mice
The effects of miR-149 on 5-8F and DNP-induced 6-10B cell metastasis were determined in vivo as described previously with some modifications. 25 Briefly, 100 μL (10 × 10 4 ) of 5-8F cells transfected with miR-149-inhibitor were mixed with 100 μL (5 mg/mL) Matrigel, and respectively injected into the tail veins of nude mice (10 mice/group). After 30 days, metastasis was evaluated by measuring the metastatic node numbers and the weight of metastasized tumors.
6-10B cells were treated with miR-149-inhibitor, and then injected into 20 nude mice. The injected mice were randomly divided into two groups with 10 mice per group. 
| Statistical analysis
Data analysis was performed using SPSS version 18.0 software (SPSS, Inc., Chicago, IL). The results are expressed as the mean ± standard error of the mean from a minimum of three independent experiments.
The statistical significance between groups was determined by one way analysis of variance. P < 0.05 was considered to indicate a statistically significant difference.
3 | RESULTS
| Differentially expressed miRNAs in DNPtreated 6-10B cells
DNP is a specific pathogenic factor for NPC, its structure is showed Figure 1A . Our previous works showed that DNP induced NPC metastasis. 25, 26 In this experiment, we want to screen microRNAs in DNP-induced NPC metastasis. miRNA sequencing was used to screen different expression miRNAs. The results showed that the differential miRNAs in DNP treatment and untreatment chips did not overlap.
After multiple rescreening processes, the miRNAs modulated by DNP were identified using a miRNA microarray (Table 3 , Figure 1B ). miR-3687, miR-1291, miR-338-3p, miR-486-3p, hsa-miR-149, hsa-miR-5088-5p, hsa-miR-1276, and hsa-miR-642a-3p highly expressed in DNP-treated cells, and miR-1307-3p, miR-29b-1-5p, miR-1273d, miR-4741, miR-6889-5p, miR-660-3p, miR-1246, miR-500a-5p, hsa-miR500b-5p were low expression. Based on miR-149's role in tumor cell proliferation and migration, 52, 53 we focused on that miR-149 involves in NPC metastasis. miR-149 expression level was confirmed using
qRT-PCR. The data showed that miR-149 expression was significantly higher in DNP-treated cells than that in the control ( Figure 1C ,
, it is consistent with sequencing data. These indicated that DNP induces miR-149 expression. We also found that miR-149 was significantly increased in NPC tissues compared to the adjacent normal NP tissues ( Figure 1D , P < 0.05). This data showed that miR-149 is associated with NPC progress.
| MiR-149's effect on PKP3 transcription and PKP3 expression in NPC tissues
A target scan analysis revealed that 3′-UTRs of Pkp3 exists binding sites for miR-149 (Figure 2A ). Vectors containing the potential binding sites or its mutation were constructed (Figure 2A ). Luciferase activity assay was used to confirm the regulation of miR-149 to Pkp3 gene.
The results showed that the transcript activity of Pkp3 gene was significantly decreased when being transfected with miR-149
( Figure 2B , P < 0.05). Nonetheless, in mutation of 3′ UTR, there was no significant difference between the transfected with miR-149 and the vector control ( Figure 2B ). Next, we further detected PKP3 expression in NPC biopsy tissues using immunohistochemistry. As shown in Figure 2C , PKP3 was localized in nucleus, cytoplasm and intercellular, and positive signals showed brown-yellow granules ( Figure 2C-a) . Furthermore, PKP3 was significantly decreased in NPC tissues compared to the adjacent tissues ( Figure 2C -b, P < 0.05).
And the relationship of PKP3 expression with clinicopathological features was shown in Table 4 B, Transcript activity of Pkp3 gene in the cells transfected with miR-149 was detected using luciferase activity assay. 3′untranslated region (UTR) of Pkp3 gene and Mut-UTR were amplified using PCR, and respectively cloned into the downstream of psiCHECK-2 luciferase vectors. These vectors were cotransfected into 6-10B cells with miR-149 or miR-NC. The transfected cells were analyzed by the Dual-Luciferase Reporter Assay System. NC, non-targeting control; WT, wild-type; Mut, mutation. C, PKP3 expression was detected in NPC specimens and the paired adjacent tissues using immunohistochemistry (a). b, c, d, and e, graphical illustration of PKP3 expression in NPC specimens. T, original tumor and nearby invasion; N, lymph node metastasis; M, distant metastasis. scale bar, 100 μm; PKP3, Plakophilin3. Original magnification, ×400. *P < 0.05
Western-blotting, miR-149 expression was detected using qRT-PCR. 
| DNP mediates apoptosis inhibition through regulating miR-149
The above results showed that downregulated-miR-149 inhibits cell FIGURE 5 DNP-induced NPC cell migration, invasion, and adhesion through miR-149. A, 6-10B cells were treated with miR-149-inhibitor and/or DNP, PKP3 expressions in the treated cells were detected using Western-blotting (a), GAPDH was used as an internal control. The abundance ratio of PKP3 to GAPDH was counted (b), and miR-149 expression was detected using qRT-PCR (c). B, The migration (a-d) and invasion (e-h) of the treated 6-10 cells were detected using Boden chamber assay, and the adhesion (i-k) was detected using Cell adhesion assay. a, e, and i, Blank control; b, f, and j, miR-149-inhibitor treatment; c, g, and k, DNP treatment; d, h, and l, DNP plus miR-149-inhibitor. Cell migration (m), invasion (n), and adhesion (o) was quantitatively analyzed. C, 5-8F cells were treated with mimic or miR-149-inhibitor. PKP3 in the treated cells was detected using Western-blotting (a) and quantitatively analyzed (b), and miR-149 mRNA were detected using qRT-PCR (c). D, Migration (a-c) and invasion (d-f) of the treated 5-8F cells were measured using Boden chamber assay. a and d, Blank control; b and e, Mimic treatment; c and f, miR-149-inhibitor. Data are presented as means ± S.D. from three independent experiments statistically using the Student's t test. Scale bar, 5 μm; Original magnification, ×200. NC, Non-targeting control; DNP, Dinitrosopiperazine; PKP3, Plakophilin3. *P < 0.05
Cell apoptosis of 6-10B cells treated with miR-149 and DNP. A, 6-10B cells were treated with miR-149-inhibitor and/or DNP, PKP3 expressions were detected using Western-blotting (a). GAPDH was used as an internal control. The abundance ratio of PKP3 to GAPDH was counted (b), and miR-149 mRNA was detected using qRT-PCR (c) 
| DNP-mediated miR-149 is involved in tube formation and induced F-actin expression
In the previous works, DNP has been proved to increase VEGF expression, and promotes NPC metastasis. 26 In the next study, we Our previous works indicate that DNP induces NPC cell filopodia fiber formation, 25 and some studies reported a connection between actin cytoskeleton and ciliogenesis. 55 In this experiment, These results suggest that miR-149 negatively regulates PKP3
expression. In our previous works, we found that NPC cell with high metastatic ability has a low PKP3 expression. 45 Recent studies have revealed that PKP3 loss is associated with tumor progression and metastasis in oral cavity and colon tumors. 43, 44 Clinical assay showed that NPC tissues display a significant high miR-149 and low PKP3 FIGURE 8 DNP-mediated 6-10B cell metastasis through miR-149 in vivo. A, 5-8F cells were transfected with miR-149-inhibitor or mimic, and then injected into nude mice through the tail vein. After 30 days, the mice were sacrificed and dissected, metastatic tumors were observed. The metastatic tumors were counted (a) and weighed (b). The tissue sections of metastatic tumors were made, and the sections were stained with hematoxylin and eosin (H&E) (c, d). PKP3 in the metastatic tumor was detected using immunohistochemistry (IHC) (e, f), and miR-149 was detected using qRT-PCR (g). Scale bar, 100 μm (*P < 0.05). B, 6-10B cells were transfected with miR-149-inhibitor and injected into nude mice, and then randomly divided into two groups. One group was abdominally injected with DNP. The other group was injected with saline, served as a blank control (BC). After 30 days, the metastatic tumors were counted (a) and weighed (b). The tumor sections were stained with H&E (c-e). PKP3 in the tumor was detected using IHC (f-h), and miR-149 was detected using qRT-PCR (i). Arrows, metastatic node. In H&E, scale bar, 20 μm; Original magnification, ×200. In IHC, scale bar, 100 μm; DNP, Dinitrosopiperazine; PKP3, Plakophilin3.Original magnification, ×400
expressions. These results indicated that miR-149 and PKP3 play an important role in NPC metastasis. Based on the above, we speculate that miR-149 negatively regulating PKP3 participates in NPC metastasis.
Further, experiment studies showed that DNP could induce miR-149 expression and inhibit PKP3 expression, and increase NPC cell migration, invasion, and adhesion. However, miR-149 was reported to be downregulated in various cancer and be a tumor suppressor, [34] [35] [36] [37] but an upregulated miR-149 level was reported in other tumors including NPC, 39, 40 and miR-149 promotes the proliferation, invasion, and migration of NPC cell lines. 41 In the present study, we found overexpression of miR-149 along with PKP3 lowexpression in NPC tissues and cell, and downregulation of miR-149 resulting in the increment of PKP3 expression. And the DNP-mediated PKP3 decrease was eliminated by miR-149 in NPC cells. This suggests that DNP may reduce PKP3 expression through upregulating miR-149.
It has early been reported that miR-149 family mediates cell apoptosis repression and proliferation increase. 53, 56 In our study, FACS analysis and TUNEL assay showed that miR-149 negatively regulating PKP3 participates in DNP-mediated cell proliferation and apoptosis inhibition. Additionally, DNP also induces angiogenesis in NPC cells. 26 It has been documented that ciliogenesis and angiogenesis are critical factors of cancer metastasis. 57, 58 Lastly, we also examined actin dynamics in DNP-promoted ciliary growth and the role of miR-149 in DNP-induced NPC angiogenesis. Our data showed that DNP regulated ciliary growth and angiogenesis through increasing miR-149 level. In summary, DNP, a specific pathogenic factors for NPC, was identified to downregulate PKP3 expression through elevating miR-149, and induce cell proliferation, migration, invasion, and adhesion, and finally promotes NPC metastasis (Figure 8 ). This provides a new avenue for NPC metastasis research and novel immunotherapeutic strategy.
